Add Yahoo as a preferred source to see more of our stories on Google. Veozah, also known as fezolinetant, blocks the nerve pathways in the brain that trigger hot flushes - Astellas /Astellas A daily ...

A new daily tablet designed to alleviate hot flushes and night sweats could offer a significant breakthrough for around 500,000 menopausal women, health officials have indicated.

Many women are unable to take HRT due to existing medical conditions, such as a history of blood clots. Furthermore, some ...

A daily tablet could help half a million women who suffer from hot flushes. The National Institute for Health and Care Excellence (Nice) has recommended that the NHS prescribe its first non-hormonal ...

In the final draft guidance published today, NICE recommended the fezolinetant 45mg tablet for women experiencing moderate to severe hot flushes and night sweats.

You’ve had a long day, a pounding headache, and you drop an effervescent paracetamol tablet into a cup of green tea instead of water. It’s convenient, warm and soothing. But here’s the catch: it might ...

An NHS regulator has announced that half a million women who can’t take or don’t want HRT will finally now be offered a non-hormonal option for menopausal hot flushes ...

Veoza, also known as fezolinetant, will be offered to women for whom HRT is unsuitable ...

A new treatment option for menopausal hot flushes and night sweats can be used in the NHS when hormone replacement therapy (HRT) is not suitable. Fezolinetant (also called Veoza and made by Astellas ...

Data include a concurrent assessment of results collected from PGI and AMRA instruments, insights into clinically meaningful changes in HAE attack symptoms, and support for hierarchical ranking of RAP ...

GPs are to be given a new non-hormonal prescribing option for menopausal hot flushes and night sweats, as NICE has expressed its support for fezolinetant. Final NICE draft guidance issued today ...